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Midtermresultsofendovascularstentgraft treatmentfor
descendingaorticaneurysmsincludinghigh-riskpatients
Mittelfristige Ergebnisse der Behandlung von Aneurysmen der Aorta
descendens mit endovaskulären Prothesen unter Einschluss von
Hochrisikopatienten
Abstract
Methods: 21 patients (17 men, 4 women; mean age 66.1 years, range
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Zusammenfassung
Methoden: 21 Patienten (17 Männer, 4 Frauen, Altersdurchschnitt
66,1 Jahre, Bereich 29-90 Jahren) mit 15 echten Aortenaneurysmen
und 6 B-Typ Dissektionen wurde eine Talent
TM Endoluminal Prothese
eingesetzt im Zeitraum Februar 2000 - Juli 2003. In 3 Fällen war ein
Überstenten der linken A. subclavia, in einem weiteren Fall der linken
A. carotis communis notwendig.
Resultate: 2 Patienten (9,5%) verstarben innerhalb der ersten 30 Tage
(ein Myokardinfarkt, eine Pneumonie). 2 Patienten erlitten eine Hirn-
ischämie, welche eine Revaskularisierung erforderlich machte. Weder
ParaplegiennochSchlaganfälletratenauf.EineEndoleckageerforderte
zusätzliches Stenten. Keiner der Patienten benötigte Konversion. Die
Nachsorgephase,imDurchschnitt25,4Monate,-spanne:0-39Monate,
wurde zu 100% durchgeführt. Währenddessenverstarbenzwei weitere
Patienten an einem Myokardinfarkt (9,5%). Die oben erwähnte Endo-
leckage, aber keine Spätstadienmigration wurde in den verbleibenden
Patienten festgestellt. In allen Fällen blieb der Durchmesser der Ge-
fäßendoprothese offen.
Schlussfolgerung:DieAneurysmabehandlungimBereichderabsteigen-
den Aorta thoracica mit endovaskulären Prothesen weist akzeptable
Mortalitäts- und Morbiditätsraten auf, auch bei Hochrisikopatienten.
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erfordert bei einer Minderheit der Fälle eine Revaskularisierung.
Schlüsselwörter: Aneurysma Aorta thoracalis descendens, Stentgraft,
mittelfristige Behandlungsergebnisse
Introduction
Descendingaorticaneurysmhasanincidenceofapproxi-
mately3in100,000peopleperyear.Themortalitywithin
five years is about 50% for untreated aneurysms [1].
Acute aortic dissection affects 10 to 20 individuals per
million in western populations [2], [3].
Treatment of patients with aneurysms of the descending
aorta still remains a challenge. Open surgical repair with
graft implantation has been the standard therapy for pa-
tients with asymptomatic descending aortic aneurysms
larger than 5-6.5 cm, while aortic dissections without
complicationsgenerallyhavebeentreatedconservatively
[4],[5].Withinthelastyears,newandmuchlessinvasive
treatment modalities have been developed. In 1991 the
first stent graft implantation was reported for a thoracic
aortic lesion [6]. Since then there has been a major de-
velopmentingraftconfigurationandsomeclinicalexperi-
ences have been published since the first clinical series
were published by the Stanford group in 1994 [7]. We
report our midterm results after stent graft repair of
descending aortic aneurysms focusing on cerebral and
spinal cord ischemia in high risk patients.
Patients, material and methods
Between February 2000 and July 2003 a total of 21 pa-
tients with lesions of the descending thoracic aorta were
treatedwithendovascularstentgraftingingeneralanaes-
thesia. Informed consent was obtained from all patients.
Generalinclusioncriteriawere:adequatevascularaccess
through the iliac arteries and the abdominal aorta, ad-
equate landingzonefreeof thrombuswith minimalcalci-
fication, aortic neck diameter <44 mm, and a length of
at least 15 cm. Indication for endovascular surgery in
trueaneurysmswereadiameter>50mmandsignificant
risk factors (Table 1) with a high risk for open surgery. In
dissectionsendovascularstentingwasindicatedforacute
dissection in patients with hypertension which were re-
fractory to medical treatment of pain with clinical signs
of malperfusion of the lower limbs. Patients in the study
underwent preprocedural imaging with spiral computed
tomography(CT)using3-mmslices.Incasesofdissection
preoperative assessment included visualisation of the
false lumen and re-entry sites.
Table 1: Risk factors in 21 patients undergoing endovascular
repair of the descending thoracic aorta
Within the 40 months period, 21 (17 men, 4 women;
mean age 66.1 years, range 29-90 years) patients with
aortic pathologies were evaluated at our institution with
15 true aneurysms and 6 type B-dissections (Stanford
classification). The aneurysms had a mean diameter of
6.1 cm (min.-max. range: 3.2-7.1 cm). All of the patients
withpathologiesofthedescendingaortawerenotsuitable
foropensurgerybecauseoftheircomorbiditiesandtheir
clinical classification (ASA mean: 2.7). Patients with ASA
score = 3 were defined as high risk patients. All 21 pa-
tients were evaluated electively.
A team of two vascular surgeons performed the proced-
ures using a Talent
TM Stent Graft System (World Medical,
a division of Medtronic Vascular, Sunrise, FL, USA) in all
cases with an oversize of 4-6 mm. 19 procedures were
performed in the operating room (OR) under general an-
aesthesia and endotracheal intubation, 2 in local anaes-
thesia. Patients were placed supine and slightly (20-30
degrees) rotated to the right on a fluoroscopic image
compatible operating table. Perioperative imaging was
performed using a mobile C-arm machine. Intravenous
heparin (10,000 IU) was administered as a bolus dose.
In all cases we performed a single shot antibiotic prophy-
laxis by application of a 2
nd generation cephalosporine.
If it was necessary to cover the left subclavian artery,
neither a transposition nor a carotid-subclavian bypass
wasperformedbeforeoverstentingthesubclavianartery.
The decision whether to reconstruct the left subclavian
arterywasmadeafteroverstentingaccordingtothemajor
clinical aspects. In one case a carotid bypass was per-
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aortic lumen
formed before procedural occlusion of the left common
carotid artery.
Usually the right femoral artery was exposed by cutdown
and controlled proximally and distally. Nearly in all cases
a 0.035 inch Terumo guidewire (Terumo
®, Frankfurt am
Main, Germany) was inserted over a sheath and pos-
itioned in the ascending aorta. This was followed by the
introduction of a 6-F pigtail catheter and an angiography
(Figure 1) of the aortic arch and the descending aorta
using a high pressure injection-pump with a non-ionic
contrast medium (Imeron
®, Altana Pharma, Germany).
After marking the aortic arch with its branches as well as
thedescendingaortaandthelandingzoneonthescreen,
a stiff guide wire was inserted and the angiography
catheter removed. A delivery sheath (22, 24 or 25 F) was
introduced with the punction of the common femoral
artery. After pharmacologically controlled hypotension
was induced (RR <80 mmHg), the stent graft was de-
ployed underX-ray guidance(Figure2). The proximaland
distal end of the device were dilated using a catheter to
achieve optimal graft contact to the aortic wall. A final
arteriogramverifiedsealingoftheaorticlesion.Theintro-
ducersheathwasremovedandthearterysutured.Wound
closure completed the procedure.
Figure 2: Intraoperative x-ray of stent graft, guide wire inside
stent lumen
Patients with cardiovascular risk factors (Table 1) were
treated with 300 mg aspirin per day.
Follow up with clinical examination and CT scans was
performed at discharge, 3, 6, and 12 months after and
then annually. Aortic size, perfusion of the false lumen,
endogenousleakagesandgraftmigrationwereevaluated.
Results
For the aneurysms, the procedures took 97.8 minutes
(average; range was 55-145 minutes). Mean blood loss
was 163.3 ml (50-350 ml), mean contrast agent dosage
56.7ml(45-70ml).Inoneofthecaseswefoundanearly
distal endoleak after the procedure. This patient with
peripheralleakageremainedwithoutsurgicalintervention,
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tients were discharged from the ward after 10.1 days in
average. Within 30 days 2 patients died: one of myocar-
dialinfarction,andoneofseverepneumonia.Inonecase
the left common carotid artery had to be bypassed using
a carotid-carotid graft before stenting the aorta. In 3 pa-
tients we had to overstent the left subclavian artery,
thereof in two cases a subclavian steal syndrome with
significant neurological deficit (markedly reduced vigil-
ance,noperipheralneurologicaldeficits)developed.After
excluding cerebral haemorrhage using CT we had to per-
form a carotid-subclavian bypass in the two, and a sub-
clavian transposition in the third case on the first post-
operative day. After revascularisation both patients be-
came asymptomatic immediately.
For the B-dissections, the procedures took 75 minutes
(average; range was 55-95 minutes). Mean blood loss
was 141.7 ml (50-300 ml), mean contrast agent dosage
55 ml (45-70 ml). The patientsweredischargedfrom the
ward after 10.7 days in average.
21of21procedureswereprimarilytechnicallycompletely
successful without conversion to open surgery. Within
the follow-up period (mean 25.4 months) another two
patients(onewithananeurysm,theotherwithaB-dissec-
tion) died of myocardial infarction. There was no rupture
ofaneurysmordislocationofstentgraftduringtheobser-
vation period. The postprocedural data are summarized
in Table 2.
Table 2: Postprocedural data in 21 patients undergoing
endovascular repair of the descending thoracic aorta
Discussion
Catheter-associated techniques have changed the face
ofmodernvascularsurgery.Thetreatmentofaneurysms
ofthedescendingaortausingendovascularstentsisone
of the more recent advances in treatment, still receiving
increasing attention as alternative to open surgery. Sev-
eral reports have shown the feasibility of stent graft
treatmentofaneurysmsofthedescendingthoracicaorta
[8], [9], [10]. 30 day mortality ranges from 0%-20% in
different reports [8], [9], [11], [12], [13] which is encour-
aging although long term results are unknown [14], [15].
For patients with high risk from concomitant diseases,
for patients with previous thoracic operations, and for
those with multiple traumas the endoluminal technique
offersanalternativetoopensurgeryalthoughendolumin-
al surgery is accompanied by complications as well as
open surgery [8], [9], [16], [17]. The often discussed 6
cm diameter threshold reflects the surgeon's reluctance
to open repair because of serious risks of morbidity and
mortality. In our opinion a diameter >5 cm, or twice the
sizeofanadjacentnonaneurysmalaorticsegmentseems
to be more reasonable [18].
OuraverageproceduretimeforaneurysmsandB-dissec-
tionstogetherwas91.3minutes(range55-145minutes),
and correlates well with data of other groups [18], [19],
[20],whereasmuchlongeroperatingtimesaredescribed
in literature [21].
In our investigation the cumulative 30-day-mortality-rate
was 9.5% and correlates well with comparable patient
groups [21], [19], [20]. However, all deaths of 4 out of
21 patients were not associated with endovascular
treatment:Twopatientsdiedofmyocardialinfarctionand
pneumonia within 30 days after stenting. Total mortality
during follow-up (mean 25.4 months) was 19% (4/21).
The 4.8% (1/21) incidence of endoleaks in our study is
in the lower rangeof comparablestudies[11], [22], [21],
[19]. In the case with a small distal endoleak we waited
3 months for spontaneous sealing, and then performed
a second procedure, overstenting the leak successfully.
The deployment of endovascular stent grafts in the
thoracic aorta may cause devastating neurological com-
plications. In our patients we saw no stroke as described
from other groups who explain those complications by
severehypovolaemiainthosepatientstreatedemergently
or by alterations of the aorta by the guidewire during its
passage through the arch and consecutive cerebral em-
bolism [21]. We overstented the left common carotid
artery after bypassing the vessel by a carotid-carotid
bridgeinonecase,andoccludedtheleftsubclavianartery
in 3 out of 21 cases (14.3%) and found a postoperative
neurological deficit in 2 patients i.e. 9.5%. In those two
patientswhosebloodpressurehadbeenextremelystable
during the operative procedure we found a psychological
alterationwhichwethoughthaditsoriginintheoccluded
left subclavian artery. A consecutive subclavian steal
syndromecouldbedocumentedusingduplexsonography.
The brain scintigrams were recorded to verify the sup-
posed steal phenomenon in the patients suffering from
a temporary organic brain syndrome.
So we decided to perform a transposition in one and a
carotid-subclavianbypassintheotherpatientonthefirst
postoperativeday, andbothpatientswereasymptomatic
indeed immediately after revascularisation. This experi-
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[18]. Another dreaded complication, paraplegia, results
fromspinalcordischemiasecondarytointercostalartery
occlusion, and is described in about 7% of the cases [9],
[11], [12], [21]. In our patients no paraplegia occurred.
As described by others [21] we routinely increase the
mean blood pressure to about 90 mm Hg for 24 hours
immediately after exclusion of the aneurysm. A drainage
of the cerebrospinal fluid as described in literature [21]
wasperformedinnoneofourpatientsbecausethebene-
fit in respect to paraplegia is not yet definitively proven
[23], [24], [25], [26].
Patientswithacuteorchronictype-B-dissectionrepresent
a cohort in whom the indication for stent graft treatment
is still debated. In our study we treated 6 patients with
acutedissectionusingendografts.Indicationsforendovas-
cular treatment of B-dissections were: a progressive dis-
section, malperfusion of organs, therapy-refractory pain
and/or hypertension. In all cases the entry site was
closed. In two of our type B dissection patients (33.3%)
four months after treatment the false lumen was still
patent but the patients did not have any symptoms. The
aortaofbothpatientsdidnotshowprogressivedilatation.
Becauseofalongdissectioninbothcaseswithperfusion
of the celiac trunk, the superior mesenteric artery and
the left renal artery through the false lumen, we decided
not to cover the re-entry site but to treat it conservatively
inordertoavoidparaplegiaafterocclusionofsomepairs
of intercostal arteries [27], [28] as well as mesenteric
ischemia. In the remaining cases the false lumen was
obliterated within the first follow up examination period,
and the patients did well. Dissections proximal to the
endografts have not been observed during the follow-up.
Conclusions
In summary our results demonstrate that endovascular
treatmentofthedescendingaortaisfeasiblewithaccept-
able early complication rates and acceptable mean term
resultseveninhightriskpatients.Proceduraloverstenting
of the subclavian artery requires subclavian revascular-
isation in the minority of cases. In selected patients en-
dovasculartreatmentmaybethemostsuitabletherapeut-
ic option.
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